← Eichor
Study identifier: NCT05131035 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk

Condition: Psychosis · Prodromal Schizophrenia · Prodromal Symptoms  ·  Sponsor: Northwell Health

PhaseNA
Planned participants54
Who can joinAll sexes, 14 Years to 20 Years
Healthy volunteersNo

About this study

This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directly to social functioning, which in turn, represents a vulnerability factor for psychosis. This remotely-delivered intervention combining targeted cognitive training exercises and group support was developed to directly impact processing speed, and at the same time, boost motivation and engagement in adolescents at risk for schizophrenia and other psychotic disorders.

This description comes directly from the study's public registry record.

Talk to the study team

Ricardo E Carrion, Ph.D.  ·  718-470-8788  ·  rcarrion@northwell.edu

Danielle McLaughlin, M.A.  ·  718-470-8375  ·  dmclaugh@northwell.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Northwell Health- The Zucker Hillside HospitalGlen Oaks, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05131035